BioLineRx Ltd. (BLRX) Gross margin 2023–2025
BioLineRx Ltd. (BLRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
80.5%FY2025 · since FY2023: 23.1% → 80.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 80.5% | +12.5 pp |
| FY2024 | 68.0% | +44.9 pp |
| FY2023 | 23.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice